UBS Group’s ProQR Therapeutics PRQR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.33M | Sell |
|
|||||
|
2025
Q1 | $2.38M | Sell |
|
|||||
|
2024
Q4 | $6.12M | Buy |
|
|||||
|
2024
Q3 | $5.28K | Sell |
|
|||||
|
2024
Q2 | $45.7K | Buy |
|
|||||
|
2024
Q1 | $11.4K | Buy |
|
|||||
|
2023
Q4 | $7.72K | Sell |
|
|||||
|
2023
Q3 | $13.1K | Buy |
|
|||||
|
2023
Q2 | $7.58K | Buy |
|
|||||
|
2023
Q1 | $7.67K | Buy |
|
|||||
|
2022
Q4 | $10.9K | Sell |
|
|||||
|
2022
Q3 | $4K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $675K | Sell |
|
|||||
|
2021
Q3 | $787K | Buy |
|
|||||
|
2021
Q2 | $418K | Sell |
|
|||||
|
2021
Q1 | $599K | Sell |
|
|||||
|
2020
Q4 | $1.98M | Sell |
|
|||||
|
2020
Q3 | $2.29M | Sell |
|
|||||
|
2020
Q2 | $2.93M | Sell |
|
|||||
|
2020
Q1 | $2.65M | Sell |
|
|||||
|
2019
Q4 | $5.03M | Buy |
|
|||||
|
2019
Q3 | $2.6M | Sell |
|
|||||
|
2019
Q2 | $4.25M | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $45M | Buy |
|
|||||
|
2018
Q3 | $4K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $9K | Buy |
|
|||||
|
2017
Q4 | $6K | Sell |
|
|||||
|
2017
Q3 | $12K | Buy |
|
|||||
|
2017
Q2 | $9K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $6K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $13K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $8K | Sell |
|
|||||
|
2015
Q3 | $18K | Buy |
|
|||||
|
2015
Q2 | $5K | Sell |
|
|||||
|
2015
Q1 | $12K | Buy |
|
|||||
|
2014
Q4 | $10K | Buy |
|